Livforsakringsbolaget Skandia’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $194K | Hold |
3,087
| – | – | 0.01% | 335 |
|
|
2025
Q4 | $205K | Hold |
3,087
| – | – | 0.01% | 339 |
|
|
2025
Q3 | $208K | Sell |
3,087
-300
| -9% | -$23.7K | 0.01% | 352 |
|
|
2025
Q2 | $296K | Hold |
3,387
| – | – | 0.01% | 322 |
|
|
2025
Q1 | $231K | Hold |
3,387
| – | – | 0.01% | 358 |
|
|
2024
Q4 | $263K | Hold |
3,387
| – | – | 0.01% | 343 |
|
|
2024
Q3 | $227K | Buy |
3,387
+2,520
| +291% | +$207K | 0.01% | 390 |
|
|
2024
Q2 | $98.2K | Hold |
867
| – | – | 0.01% | 292 |
|
|
2024
Q1 | $120K | Hold |
867
| – | – | 0.01% | 285 |
|
|
2023
Q4 | $108K | Buy |
867
+367
| +73% | +$37.5K | 0.01% | 303 |
|
|
2023
Q3 | $46.6K | Hold |
500
| – | – | 0.01% | 336 |
|
|
2023
Q2 | $64.3K | Hold |
500
| – | – | 0.01% | 301 |
|
|
2023
Q1 | $58.1K | Hold |
500
| – | – | 0.01% | 313 |
|
|
2022
Q4 | $56.6K | Hold |
500
| – | – | 0.01% | 312 |
|
|
2022
Q3 | $40K | Sell |
500
-1,900
| -79% | -$161K | ﹤0.01% | 353 |
|
|
2022
Q2 | $179K | Sell |
2,400
-800
| -25% | -$73K | 0.02% | 355 |
|
|
2022
Q1 | $409K | Hold |
3,200
| – | – | 0.03% | 299 |
|
|
2021
Q4 | $430K | Sell |
3,200
-2,400
| -43% | -$345K | 0.03% | 290 |
|
|
2021
Q3 | $765K | Hold |
5,600
| – | – | 0.05% | 263 |
|
|
2021
Q2 | $598K | Hold |
5,600
| – | – | 0.04% | 319 |
|
|
2021
Q1 | $503K | Hold |
5,600
| – | – | 0.04% | 315 |
|
|
2020
Q4 | $518K | Buy |
5,600
+1,600
| +40% | +$143K | 0.04% | 300 |
|
|
2020
Q3 | $412K | Hold |
4,000
| – | – | 0.04% | 263 |
|
|
2020
Q2 | $405K | Hold |
4,000
| – | – | 0.05% | 264 |
|
|
2020
Q1 | $269K | Buy |
4,000
+1,600
| +67% | +$99.6K | 0.04% | 289 |
|
|
2019
Q4 | $131K | Sell |
2,400
-1,600
| -40% | -$75.9K | 0.02% | 451 |
|
|
2019
Q3 | $149K | Buy |
4,000
+800
| +25% | +$31.1K | 0.02% | 464 |
|
|
2019
Q2 | $120K | Hold |
3,200
| – | – | 0.01% | 476 |
|
|
2019
Q1 | $95K | Hold |
3,200
| – | – | 0.01% | 503 |
|
|
2018
Q4 | $96K | Buy |
+3,200
| New | +$102K | 0.01% | 464 |
|
|
2017
Q4 | – | Sell |
-6,400
| Closed | -$78K | – | 707 |
|
|
2017
Q3 | $78K | Hold |
6,400
| – | – | 0.01% | 682 |
|
|
2017
Q2 | $117K | Hold |
6,400
| – | – | 0.01% | 636 |
|
|
2017
Q1 | $136K | Buy |
+6,400
| New | +$125K | 0.01% | 616 |
|
Other funds holding DXCM
VCM
VPM
Livforsakringsbolaget Skandia's DXCM Position: Q1 2026 in Review
Livforsakringsbolaget Skandia held its DexCom (DXCM) position steady in Q1 2026 at 3,087 shares worth $194K. The position accounts for 0.01% of the portfolio, ranked #335.
Livforsakringsbolaget Skandia first reported a position in DXCM in Q1 2017 and has held it in 33 quarters since. The position peaked at $765K in Q3 2021. 959 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Livforsakringsbolaget Skandia held 3,087 shares of DexCom worth $194K as of Q1 2026.
- Livforsakringsbolaget Skandia left its DexCom share count unchanged in Q1 2026.
- DexCom made up 0.01% of Livforsakringsbolaget Skandia's portfolio in Q1 2026, its #335 holding.
- Livforsakringsbolaget Skandia first reported a position in DexCom in Q1 2017 and has held it in 33 quarters since.
- Livforsakringsbolaget Skandia's DexCom position peaked at $765K in Q3 2021.
- 959 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Livforsakringsbolaget Skandia's 13F filing for Q1 2026, filed 5 May 2026.